Remi Martin-Fardon is a Staff Scientist in the Molecular and Integrative Neurosciences Department of The Scripps Research Institute, La Jolla. He received his Ph.D. degree in biochemistry and molecular biology at The University of Montpellier II (France) in 1996.He completed his B.S. degree in biology and physiology at the University of Montpellier II (France) in 1989. He received his M.S. degree in physiology and pharmacology at the University of Montpellier II (France) in 1990. He is currently the Member of 7 professional organizations that include the American Society for Pharmacology and Experimental Therapeutics (ASPET), the Research Society on Alcoholism (RSoA), and the College on Problems of Drug Dependence (CPDD). He is serving as a Reviewer for 13 international journals that include Pharmacology Biochemistry and Behavior, The Journal of Pharmacology and Experimental Therapeutics, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Journal of Neuroscience, Behavioral Neuroscience, European Neuropsychopharmacology, The International Journal of Neuropsychopharmacology, Journal of Psychopharmacology. His research interests include the identification of new pharmacological targets for the prevention of drug relapse, the neurobiological basis of chronic vulnerability to relapse, with an emphasis on identifying neural substrates responsible for the distinctly compulsive nature of cocaine seeking, as compared to behavior motivated by natural rewards. He is also interested in elucidating the selective role of various brain targets such as Group II metabotropic glutamate receptors, s1 receptors, and the orexin/hypocretin system on drug seeking.
Biography Updated on 13 January 2011